《International Journal of Molecular Sciences》:So Fragile, So Human: Noncoding DNA Regions Orchestrating Gene Expression Involved in Neurodevelopmental Disorders and in Human Brain Evolution
Carolina Marenco,
Giorgia Pozzolini,
Martina Casciaro,
Matheo Morales,
Cristiana Barone,
Delia Morciano,
Cristian Barillari,
Elvira Zakirova,
Gabriele Antoniazzi and
Silvia K. Nicolis
+ 5 authors
【字体:
大中小
】
时间:2026年03月20日来源:International Journal of Molecular Sciences 4.9
为了探索这些前沿问题,研究人员Carolina Marenco, Giorgia Pozzolini, Martina Casciaro等学者在《International Journal of Molecular Sciences》上发表了一篇综述文章,系统性地阐述了非编码DNA调控网络、NDDs遗传风险以及人类大脑进化三者之间的深刻联系。文章的核心论点是:调控基因表达的三维DNA相互作用网络是连接NDDs(特别是ASDs)的遗传病因与人类特异性大脑特征进化的共同分子框架。调控序列的突变(无论是新发突变还是罕见隐性遗传突变)可以破坏这一网络的稳定性,导致疾病;而人类进化过程中在同类调控序列(如HARs)上积累的特异性变化,则可能通过微调同一网络,塑造了独特的人类心智。
罕见隐性遗传的HARs突变与自闭症谱系障碍相关联。在近亲家系中的研究发现,位于HARs内的罕见、隐性遗传的DNA序列变异(拷贝数变异CNV或单核苷酸变异SNV)在ASD先证者中显著富集,是ASD的风险因素。这些HARs在报告基因检测中具有增强子活性,并且它们通过长程相互作用连接的靶基因中,许多与ASD相关。值得注意的是,SOX2的结合位点在携带此类罕见双等位基因突变的HARs中显著富集,且SOX2本身也是这些HARs相互作用涉及的高频基因。这表明,SOX2在维持长程相互作用方面的功能,可能参与了这些HARs突变致病的机制。更有趣的是,一些ASD相关的新发单核苷酸变异与HARs中的人类特异性核苷酸置换发生在同一核苷酸位置上,影响相同的转录因子结合位点,为疾病与进化在分子水平上的直接关联提供了例证。https://mdpi-res.com/ijms/ijms-27-02785/article_deploy/html/images/ijms-27-02785-g009b-550.jpg" caption="">https://mdpi-res.com/ijms/ijms-27-02785/article_deploy/html/images/ijms-27-02785-g009b-550.jpg" caption="figure 9. neurodevelopmental disorders and human-specific evolution are associated with mutations within the same regulatory dna sequences (hars). (a) rare recessive dna sequence variants (cnvs or snvs) within hars represent risk factors for autism spectrum disorders [51,52,53]. (b) the long-range connectivity of hars affected by such rare biallelic mutations identifies genes potentially relevant for asds. notably, recognition sites for transcription factor sox2 are significantly enriched within hars involved in such interactions; further, sox2 is also highly enriched among genes involved in such interactions [36,51,52,53]. the function of sox2 in the maintenance of long-range interactions [3] may play a role in the mechanism whereby these mutations cause disease. hars (and hges) carry human-specific substitutions (hsubs), enriched in binding sites of transcription factor fos [31], a known sox2 binding partner in nsc [55]. fos binding consensus sites are enriched within hsubs, leading to differential enhancer activity in an mpra assay [31]; sox2 and fos together might contribute to human-specific enhancer evolution. (c) de novo snv associated with asds (see figure 4) can overlap single-nucleotide human-specific substitutions and affect transcription factor binding sites (red or green triangles). inthe